Source: Eur Respir J 2010; 36: 285
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gutierrez P., Closa D., Piñer R., Bulbena O., Menndez R., Torres A.. Macrophage activation in exacerbated COPD with and without community-acquired pneumonia. Eur Respir J 2010; 36: 285

Member's Comments

No comment yet.

Related content which might interest you: Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Enhanced PMN response in chronic bronchitis and community-acquired pneumonia Source: Eur Respir J 2004; 24 : 772-778 Year: 2004 Estimation of inflammatory process activity in community-acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 106s Year: 2006 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Corticosteroids in severe pneumonia Source: Eur Respir J 2008; 32: 259-264 Year: 2008 Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016 Inflammatory pattern in bacteriemic community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Distinguishing features of pneumonia and exacerbations in COPD Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 Preventing community-acquired pneumonia Source: International Congress 2019 – Respiratory infections: prevention is better than cure Year: 2019 is hypercapnia associated with severe forms of community-acquired pneumonia? Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls Source: Annual Congress 2006 - Molecular airway biology Year: 2006 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 Community-acquired pneumonia: impact of COPD Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Source: Eur Respir J 2002; 20: 990-995 Year: 2002 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia Source: Eur Respir J 2013; 41: 1378-1385 Year: 2013